A Phase I/II Study of the Safety and Efficacy of Sernova's Cell Pouch for Therapeutic Islet Transplantation
Latest Information Update: 22 Aug 2024
At a glance
- Drugs Islet cell replacement therapy (Primary)
- Indications Type 1 diabetes mellitus
- Focus Adverse reactions; First in man; Proof of concept
- 15 Aug 2024 According to a Sernova media release, Dr. Piotr Witkowski MD PhD, Professor of Surgery and Director of the Pancreatic and Islet Transplant Program is the lead investigator of this trial and will be present new data from this phase 1/2 trial in a short oral presentation at the upcoming European Association for the Study of Diabetes (EASD) taking place September 9-13, 2024 in Madrid, Spain.
- 22 Mar 2023 According to a Sernova media release, company announced that an abstract on first cohort of this trial has been selected for an oral podium presentation at the upcoming American Diabetes Association (ADA) 83rd Scientific Sessions, to be held from June 23-26, 2023, in San Diego, CA. It will also be published on the journal Diabetes website.
- 22 Dec 2016 According to a Sernova media release, this study is sponsored by JDRF.